4.3 Article

Starting insulin therapy with basal insulin analog or premix insulin analog in T2DM: a pooled analysis of treat-to-target trials

Related references

Note: Only part of the references are listed.
Editorial Material Medicine, General & Internal

Rosiglitazone no longer recommended

[Anonymous]

LANCET (2008)

Article Medicine, General & Internal

Addition of biphasic, prandial, or basal insulin to oral therapy in type 2 diabetes

Rury R. Holman et al.

NEW ENGLAND JOURNAL OF MEDICINE (2007)